MedPath

SWOG

SWOG logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1956-01-01
Employees
101
Market Cap
-
Website
http://www.swog.org

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Phase 2
Recruiting
Conditions
Stage IIIB Prostate Cancer AJCC v8
Prostate Adenocarcinoma
Stage IIIC Prostate Cancer AJCC v8
Interventions
Procedure: Biospecimen Collection
Procedure: Chest Radiography
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: PSMA PET Scan
Procedure: Surgical Procedure
First Posted Date
2023-04-10
Last Posted Date
2024-07-08
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
44
Registration Number
NCT05806515
Locations
🇺🇸

Mercy Cancer Center �� Carmichael, Carmichael, California, United States

🇺🇸

Mercy San Juan Medical Center, Carmichael, California, United States

🇺🇸

City of Hope at Irvine Lennar, Irvine, California, United States

and more 130 locations

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Phase 2
Recruiting
Conditions
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Interventions
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Biological: Ramucirumab
First Posted Date
2022-12-08
Last Posted Date
2024-06-11
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
66
Registration Number
NCT05642572
Locations
🇺🇸

Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States

🇺🇸

Saint Francis Cancer Center, Colorado Springs, Colorado, United States

🇺🇸

Illinois CancerCare-Eureka, Eureka, Illinois, United States

and more 70 locations

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Phase 3
Recruiting
Conditions
Malignant Solid Neoplasm
Interventions
Procedure: Biospecimen Collection
Procedure: Pneumatic Compression Therapy
Procedure: Cryocompression Therapy
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2022-12-08
Last Posted Date
2025-04-02
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
777
Registration Number
NCT05642611
Locations
🇺🇸

McLeod Regional Medical Center, Florence, South Carolina, United States

🇺🇸

Spartanburg Medical Center, Spartanburg, South Carolina, United States

🇺🇸

Gibbs Cancer Center-Pelham, Greer, South Carolina, United States

and more 26 locations

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2
Recruiting
Conditions
Primary Mediastinal (Thymic) Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma
Transformed Marg Zone Lymph to Diff Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Grade 3b Follicular Lymphoma
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
Interventions
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Other: Patient Observation
Procedure: Positron Emission Tomography
First Posted Date
2022-12-01
Last Posted Date
2024-12-20
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
396
Registration Number
NCT05633615
Locations
🇺🇸

Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States

🇺🇸

Highlands Oncology Group - Rogers, Rogers, Arkansas, United States

🇺🇸

Highlands Oncology Group, Springdale, Arkansas, United States

and more 73 locations

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Phase 3
Recruiting
Conditions
Stage IV Lung Cancer AJCC v8
Recurrent Lung Non-Small Cell Carcinoma
Interventions
First Posted Date
2022-12-01
Last Posted Date
2025-03-30
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
700
Registration Number
NCT05633602
Locations
🇺🇸

Northside Hospital, Atlanta, Georgia, United States

🇺🇸

NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States

🇺🇸

City of Hope at Irvine Lennar, Irvine, California, United States

and more 560 locations

Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study

Not Applicable
Active, not recruiting
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Hormone Receptor-Positive Breast Carcinoma
Interventions
Other: Best Practice
Procedure: Biospecimen Collection
Procedure: Endocrine Drug Therapy
Behavioral: Health Education
Other: Questionnaire Administration
Other: Symptom Specific Assessment Tool
First Posted Date
2022-10-05
Last Posted Date
2025-04-03
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
565
Registration Number
NCT05568472
Locations
🇺🇸

Kingman Regional Medical Center, Kingman, Arizona, United States

🇺🇸

Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

🇺🇸

Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States

and more 484 locations

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Phase 3
Recruiting
Conditions
Plasma Cell Myeloma
Interventions
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2022-09-30
Last Posted Date
2024-05-06
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
510
Registration Number
NCT05561387
Locations
🇺🇸

Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States

🇺🇸

Illinois CancerCare-Carthage, Carthage, Illinois, United States

🇺🇸

Saint Anthony's Health, Alton, Illinois, United States

and more 393 locations

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

Not Applicable
Active, not recruiting
Conditions
Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm
Advanced Malignant Solid Neoplasm
Interventions
Other: Best Practice
Other: Chart Abstraction
Other: Educational Intervention
Procedure: Genomic Profile
Other: Interview
Other: Questionnaire Administration
Other: Tumor Board Review
First Posted Date
2022-07-13
Last Posted Date
2025-04-03
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
1284
Registration Number
NCT05455606
Locations
🇺🇸

Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

🇺🇸

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States

🇺🇸

Hawaii Cancer Care - Westridge, 'Aiea, Hawaii, United States

and more 69 locations

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Phase 2
Withdrawn
Conditions
Stage IVB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Recurrent Lung Non-Small Cell Carcinoma
Lung Non-Small Cell Carcinoma
Interventions
First Posted Date
2022-05-06
Last Posted Date
2024-07-09
Lead Sponsor
SWOG Cancer Research Network
Registration Number
NCT05364645
Locations
🇺🇸

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States

🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

🇺🇸

Sutter Auburn Faith Hospital, Auburn, California, United States

and more 262 locations

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase 2
Active, not recruiting
Conditions
Stage IIIC Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Advanced Lung Non-Small Cell Carcinoma
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Recurrent Lung Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8
Interventions
First Posted Date
2021-10-27
Last Posted Date
2025-05-15
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
82
Registration Number
NCT05096663
Locations
🇺🇸

Kaiser Permanente West Los Angeles, Los Angeles, California, United States

🇺🇸

Illinois CancerCare-Princeton, Princeton, Illinois, United States

🇺🇸

UPMC-Mercy Hospital, Pittsburgh, Pennsylvania, United States

and more 346 locations
© Copyright 2025. All Rights Reserved by MedPath